The CCL22-CCR4 axis could induce the expression of FoxP3 in Tregs [11] and infiltrate FoxP3 + Treg selectively into tumor sites, contributing to form an immunocompromised environment in favor of tumor growth. The gene discussed is CCL22; the disease is neoplasm.